Skip to content
Immunexpress
  • About Us
  • Sepsis
  • SeptiCyte®
  • Validation
  • Newsroom
  • Contact Us
Immunexpress
  • About Us
  • Sepsis
  • SeptiCyte®
  • Validation
  • Newsroom
  • Contact Us

Archive for July 2025

The Medical Podcast: Sepsis, Speed, and Saving Lives with Dr. Rolland Carlson

By Immunexpress | July 23, 2025
Medtech Podcast #86

Podcast summary: Dr. Rolland “Rollie” Carlson, CEO of Immunexpress is a veteran of the molecular diagnostics space. With over 25 years of leadership across Abbott, WaferGen, Asuragen, and more, Rollie is now focused on solving one of healthcare’s most urgent crises: Sepsis. In this episode, we explore why sepsis, despite causing more than 48 million…

Read More

Diagnostic performance of SeptiCyte RAPID in critically ill patients with occlusive acute mesenteric ischemia: a pilot study

By Immunexpress | July 5, 2025
PubMed

Highlights SeptiCyte RAPID may help distinguish peritonitis from inflammation in OAMI. A Score <7.4 ruled out infection in non-infected occlusive acute mesenteric ischemia. Ischemia alone did not raise SeptiScore in elective vascular surgery controls. Link: https://pubmed.ncbi.nlm.nih.gov/40446729/

Read More

About Us

Immunexpress is a privately-owned group of companies developing and commercializing revolutionary molecular diagnostics to aid clinicians in managing patients with, or suspected of, sepsis through analysis of molecular blood biomarkers from a patient’s immune system (the ‘host response’).

Additional Resources

Newsroom

Contact Us

Privacy policy

 

© [year] Immunexpress Inc. — all Rights Reserved.
425 Pontius Avenue North, Suite 470, Seattle, WA 98109 USA
+1 206.858.6436 – info@immunexpress.com

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
Scroll To Top